A variant form of X-linked chronic granulomatous disease with normal nitroblue tetrazolium slide test and cytochrome b

1983 ◽  
Vol 13 (3) ◽  
pp. 243-247 ◽  
Author(s):  
NIELS BORREGAARD ◽  
ANDREW R. CROSS ◽  
TROELS HERLIN ◽  
OWEN T. G. JONES ◽  
ANTHONY W. SEGAL ◽  
...  
PEDIATRICS ◽  
1970 ◽  
Vol 45 (5) ◽  
pp. 861-865
Author(s):  
Denis R. Miller ◽  
Henry G. Kaplan

Nitroblue tetrazolium (NBT) dye reduction by leukocytes of 21 patients receiving prednisone was significantly decreased. Nineteen percent of the patients had values similar to those found in children with chronic granulomatous disease, and 57% had heterozygous-range NBT dye reduction. A qualitative NBT dye reduction "slide test" correlated well with the quantitative assay. The uptake of particles by the phagocytes of steroid-treated patients appeared normal. The exact mechanism of corticosteroid action remains unknown. The decreased dye reduction observed in vitro suggests an induced defect of intracellular metabolism which may be related to known alterations of host defenses which occur in patients receiving these hormones.


The Lancet ◽  
1979 ◽  
Vol 313 (8123) ◽  
pp. 949-951 ◽  
Author(s):  
Niels Borregaard ◽  
KirstenStahr Johansen ◽  
Ebbe Taudorff ◽  
JohanH. Wandall

Blood ◽  
1988 ◽  
Vol 71 (2) ◽  
pp. 505-507 ◽  
Author(s):  
AJ Verhoeven ◽  
ML van Schaik ◽  
D Roos ◽  
RS Weening

The NADPH:O2 oxidoreductase catalyzing the respiratory burst in activated phagocytes from healthy individuals is not operative in phagocytes from patients with chronic granulomatous disease (CGD). In a microscopic slide test using the dye nitroblue tetrazolium (NBT), carriers of X-linked CGD can be recognized by a mosaic pattern of NBT- positive and NBT-negative cells, governed by the expression of an unaffected or an affected X chromosome, respectively. Until now, it has not been possible to detect carriers of the autosomal form of CGD (other than by family studies) because all cells of these carriers stain positive in the NBT test. We have investigated whether neutrophils from carriers of autosomal CGD can be recognized by measurement of the rate of oxygen uptake upon stimulation of the cells. It was found that with the phorbol ester PMA as a stimulus, the respiratory burst is significantly lower in autosomal CGD carriers. With serum-treated zymosan as a stimulus, no difference between controls and carriers was observed. The addition of f-Met-Leu-Phe (1 microM) to PMA-activated neutrophils of control donors caused a transient increase in oxygen consumption of about 40%. Under these conditions, an increase of more than 100% was observed in neutrophils from carriers of autosomal CGD. These findings provide a simple method for the detection of carriers of the autosomal form of CGD.


PEDIATRICS ◽  
1969 ◽  
Vol 43 (1) ◽  
pp. 122-124
Author(s):  
Richard B. Johnston

Normal phagocytes suspended in plasma when mixed with latex particles for ingestion and nitroblue tetrazolium dye will reduce the dye to a blue color which may be easily seen in a test tube. This reaction depends on the release of enzymes from phagocytic lysosomal granules after phagocytosis. Since such release is deficient in patients with CGD, no blue color develops in the tube. This has proved to be a simple, reliable, screening test which should allow the more rapid and widespread diagnosis of CGD.


Blood ◽  
1989 ◽  
Vol 73 (6) ◽  
pp. 1416-1420 ◽  
Author(s):  
CA Parkos ◽  
MC Dinauer ◽  
AJ Jesaitis ◽  
SH Orkin ◽  
JT Curnutte

Abstract Chronic granulomatous disease (CGD) is a group of inherited disorders in which phagocytic cells fail to generate antimicrobial oxidants. The various forms of CGD can be classified in terms of the mode of inheritance (either X-linked or autosomal recessive), and whether the neutrophils display the absorbance spectrum of a unique b-type cytochrome important for the function of the respiratory burst oxidase. The finding that purified neutrophil cytochrome b is a heterodimer consisting of a 91kD glycosylated and a 22kD nonglycosylated polypeptide has raised the question of which subunits are absent (or defective) in the various types of CGD. To address this question we have studied the expression of the cytochrome b subunits in three genetically distinct forms of CGD: X-linked/cytochrome b-negative (X-), autosomal recessive/cytochrome b-negative (A-), and autosomal recessive/cytochrome b-positive (A+). Using polyclonal antibodies to each of the two subunits, we prepared Western blots of lysates of intact neutrophils from ten CGD patients. In the controls and three patients with A+ CGD, both cytochrome subunits were easily detected. Consistent with the previously reported finding in five X- patients, neither subunit could be identified in neutrophils from three additional X- patients. Both subunits were also undetectable in four patients with A- CGD (three females, one male). This latter group of patients most likely bears a normal 91kD gene, since the patients are genetically distinct from the 91kD-defective X- group. The mutation in A- CGD, therefore, probably involves the 22kD gene and the eventual expression of the 22kD subunit. Furthermore, the expression of the 91kD subunit in this group of patients appears to be prevented due to the 22kD mutation in a manner converse to that seen in the X- CGD patients. Based on these studies, we hypothesize that the stable of expression of either of the two cytochrome subunits is dependent upon the other.


1985 ◽  
Vol 107 (1) ◽  
pp. 102-104 ◽  
Author(s):  
Ron S. Weening ◽  
Lesley H. Adriaansz ◽  
Corry M.R. Weemaes ◽  
Ren Lutter ◽  
Dirk Roos

1998 ◽  
Vol 103 (4) ◽  
pp. 377-381 ◽  
Author(s):  
Masahiko Tsuda ◽  
Mizuho Kaneda ◽  
Takeshi Sakiyama ◽  
Ichiro Inana ◽  
Misao Owada ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document